Hi,
Recently we are modeling the ranitidine data in pregnant women. Some of
them were sampled several times in different periods, for example, early,
late or post pregnancy. Should we put all the samplings under one ID of
the patient? or we can treat the several samplings as independent
samplings and give them different ID? Anyone has such repeated measures
experiences and any suggestions will be great appreciated.
Paul
School of Pharmacy
University of Pittsburgh
716 Salk Hall
3501 Terrace Street
Pittsburgh, PA 15261
Phone: 412-648-8546
E-mail: [email protected]